The growth of Viagra and its influence on the medicinal landscape presents a intricate question for investors. While the early sales figures were impressive, the exclusivity has lapsed, leading to a wave of off-brand https://kalelhxx827164.designi1.com/62096147/the-blue-pill-and-big-pharma-a-risky-opportunity